Two journals have retracted papers by a biologist who was recently found guilty of misconduct by his former employer, the University of Colorado Denver, bringing the total to five. The investigation report by UC Denver, which we obtained earlier this year via a public records request, had recommended one of the two newest retractions, which … Continue reading Two more retractions for former US prof who altered dozens of images
A former graduate student at the University of Hong Kong confessed to making “inappropriate modifications” to several figures in a 2013 paper in the Journal of Biological Chemistry (JBC). According to the retraction notice, the authors identified issues in 13 images while reviewing the data; the paper’s first author, Yingying Lu, copped to manipulating the … Continue reading Author admits to manipulating more than a dozen images in 2013 paper
The executive board of the Leibniz Association in Germany has reprimanded the director of its institute on aging for “grossly negligent scientific misconduct.” Besides a written reprimand, the executive board has removed Karl Lenhard Rudolph’s “passive voting rights” in association committees, and excluded the institute under his leadership from receiving funds from a multi-million Euro internal … Continue reading German institute sanctions director after finding him guilty of misconduct
On Dec. 2, 2013, Alison Lakin, the research integrity officer at the University of Colorado Denver, received a concerning email. The emailer was alleging several problems in a 2012 paper in the Journal of Clinical Investigation, co-authored by one of its high-profile faculty members. Lakin discussed the allegations with some administrators and agreed they had … Continue reading Former prof fudged dozens of images, says university
A prominent diabetes researcher based at Harvard Medical School has retracted a third paper, citing manipulation of multiple figures. Late last year, Carl Ronald Kahn—also chief academic officer at Joslin Diabetes Center—retracted two papers for similar reasons. In November, Kahn pulled a 2005 paper from The Journal of Clinical Investigation (JCI) and a month later, he retracted a 2003 paper from The … Continue reading Harvard diabetes researcher retracts third paper
A pharmacology journal has retracted a 2011 paper after concluding images in three figures had been manipulated. According to the British Journal of Pharmacology, four of the five authors claim they played no role in the manipulation. There is no comment from the remaining author, first author Ian Morecroft, a research associate at the University of … Continue reading Three figures in blood pressure paper were manipulated, says journal
It would seem that resorting to legal means to avoid editorial notices doesn’t always work. We’re coming to that conclusion after seeing yet another notice for Mario Saad, based at the University of Campinas in São Paulo, Brazil. In this case, it’s an expression of concern from the Journal of Endocrinology, on a 2005 paper that … Continue reading Journal flags another paper by diabetes researcher who sued to stop retractions
A cancer biologist based at the University of Maryland is transitioning out of research, as a journal has retracted three more of his papers. Anil Jaiswal has now lost 13 papers, including, as we reported on February 6, six retractions issued earlier this month. The Baltimore Sun reported this week that Jaiswal would no longer … Continue reading Cancer biologist stops research as his retraction count rises to 13
A researcher in Germany has logged her fourth retraction following an investigation by her former employer that found evidence of scientific misconduct. The latest retraction for Tina Wenz in the Journal of Applied Physiology mentions the probe at the University of Cologne in Germany, which recommended retracting six of her papers. One had already been … Continue reading Researcher loses 4th paper flagged by misconduct probe
Science has retracted a high-profile immunology paper after a probe concluded the corresponding author had committed misconduct. The paper — which initially caught media attention for suggesting a protein could help boost the immune system’s ability to fight off tumors — has been under a cloud of suspicion since last year, when the journal tagged … Continue reading High-profile Science paper retracted for misconduct